Results 131 to 140 of about 10,224,515 (204)

Immune checkpoint inhibitor‐induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1702-1712, October 2026.
A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn, Alexandre O. Gérard, Maëlys Labat, Zoe Apalla, Wouter van Binsbergen, Dimitra Koumaki, Valerian Rivet, Frederic Dezoteux, Damien Giacchero, Michael R. Ardern‐Jones, Kara Heelan, Jesse P. Hirner, Ander Mayor, Mariette Labots, Markus V. Starink, Conny J. van der Laken, Vincent Sibaud, Yannick S. Elshot   +17 more
wiley   +1 more source

Cerebral toxoplasmosis in a patient with systemic sclerosis under thalidomide treatment: A case report

JAAD Case Reports
Betul Macit, MD, Aakash Arora, BS, AB, Anthony M. Reginato, MD, PhD, Abrar A. Qureshi, MD, MPH   +3 more
doaj   +1 more source

Relaxin‐2: Shaping the Proteomic Landscape of Skeletal Muscle Physiology, Glucose Trafficking, and Mitochondrial Function in Rat

The FASEB Journal, Volume 40, Issue 18, 30 September 2026.
Cardioprotective hormone relaxin‐2 showed relevant effects on rat skeletal muscle by altering proteins linked to muscle function, regeneration, differentiation, mitochondrial function, glucose metabolism, and structural integrity and organization. Specifically, relaxin‐2 reduced the expression of 95 proteins, increased 32, and elicited unique proteins ...
Xocas Vázquez‐Abuín, Lucía Gómez‐Cibeira, Javier García‐Seara, Pablo de la Fuente‐López, Carlos Minguito‐Carazo, Susana B. Bravo, Manuel Otero‐Santiago, Oreste Gualillo, José Ramón González‐Juanatey, Francisca Lago, Sandra Feijóo‐Bandín, Alana Aragón‐Herrera   +11 more
wiley   +1 more source

[Microstomia as a complication of scleroderma]

, 2003
Scleroderma is a rare connective tissue disease of unknown origin. It is characterized by increased collagen deposition leading to fibrosis and degeneration of the skin and sometimes of internal organs.
Baat, C. de, Baat, P. de, Phoa, K.H.
core   +1 more source

Successful Treatment of Localized Scleroderma in Intertriginous Areas with Tofacitinib: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Xu D, Qian S, Tang Y, Bao W, Xu J.
europepmc   +1 more source

A Case of Critical Digit Ischemia in a Patient With Suspected Seronegative Scleroderma Diagnosed via Nailfold Capillaroscopy. [PDF]

Case Rep Rheumatol
Kornas M, Wang C, Mumtaz S, Dumitrascu AG, Berianu F.   +4 more
europepmc   +1 more source

Nailfold Videocapillaroscopy in Pediatric Rheumatology: Established Roles, Emerging Applications, and Future Perspectives. [PDF]

Balkan Med J
Öztürk K, Haslak F, Yıldız M, Adrovic A, Kasapçopur Ö.   +4 more
europepmc   +1 more source

Vitamin B3 (Nicotinamide) Supplementation in Primary and Scleroderma-Related Raynaud Phenomenon. [PDF]

ACR Open Rheumatol
Govender M, Tomson N, Fang J, Bakry M, Liu R, Morrisroe K, Penglase R, Dissanayake K, Tsai T.   +8 more
europepmc   +1 more source

Navigating the Unknown: Scleroderma Renal Crisis and a Fatal Cardiac Complication in a Young Patient With MCTD With Coexisting Anti-U3 RNP and Anti-RNA Polymerase III Antibodies. [PDF]

Case Rep Rheumatol
Reyes-Castro T, Nabizadeh A, Nasr R, Ngo L.   +3 more
europepmc   +1 more source

IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients. [PDF]

J Dermatol
Takahashi T, Takahashi T, Segawa Y, Oka K, Takahashi T, Asano Y.   +5 more
europepmc   +1 more source